[ad_1]
As Health Minister Arūnas Dulkys said at the meeting, in January the Government had already agreed to buy additional doses of this vaccine under a pre-agreement, the decision had to be renewed after the permanent purchase agreement concluded by the European Commission on February 8. . .
According to him, the update is also agreed that the parties will be able to acquire not only the currently produced vaccines but also the company’s future vaccines, which would be adapted to new mutations in coronavirus.
“There is an innovation that we need to know that at the time of the pre-purchase agreements of the European Commission, little else was known, little was said about possible mutations. In this case, an additional element is introduced in the agreements that the member states they will have the right to renegotiate the supply of vaccines in case the European Medicines Agency and manufacturers start to have updated vaccines adapted to mutations, “said the minister.
In total, Lithuania has decided to buy coronavirus vaccines from seven companies. So far, the European Medicines Agency (EMA) has approved three vaccines: Pfizer and BioNTech, and Moderna and AstraZeneca, all of which are used in Lithuania. The total number of vaccines currently planned to be purchased is around 9.5 million.
This week, the eighth shipment of the BioNTech and Pfizer vaccine against COVID-19 arrived in Lithuania: 22 thousand. 230 doses, a total of almost 3.1 million is planned to buy from this company. dose of vaccine.
[ad_2]
